HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium hydride → 2-(6-(1,4-Diazepan-1-yl)pyrimidin-4-ylamino)thiazole-5-carbonitrile
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 2-Chlorothiazole-5-carbonitrile | HCID 1485222 | — |
| Reactant | Tert-butyl 4-(6-aminopyrimidin-4-yl)-1,4-diazepane-1-carboxylate | HCID 21934608 | — |
| Product | 2-(6-(1,4-Diazepan-1-yl)pyrimidin-4-ylamino)thiazole-5-carbonitrile | HCID 21934651 | — |
Reaction Steps
Tert-butyl 4-(6-aminopyrimidin-4-yl)-1,4-diazepane-1-carboxylate 15-2 (0.50 g, 1.70 mmol), sodium hydride (0.136 g, 3.4 mmol) and 2-chloro-1,3-thiazole-5-carbonitrile 2-2 (0.246 g, 1.70 mmol) were treated as in Scheme 4 above. The product was purified on a C18 preparative column after treating the crude product with trifluoroacetic acid and then isolated via lyophilization. Hi-Res MS: calc: 302.1182 found: 302.1184. 1NMR (CD3OD): 8.45 ppm (s, 1H); 8.01 ppm (s, 1H); 6.16 ppm (s, 1H); 4.08 ppm (m, 2H); 3.73 ppm (m, 2H); 3.40 ppm (m, 2H); 3.32 ppm (m, 2H); 2.21 ppm (m, 2H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07115597B2 |
| Source dataset | uspto-grants-2006_10 |
| ORD ID | ord-9f9628b6f5664effb0b9babfcb481047 |
| Source note | uspto-grants-2006_10 |